Bowhead Q2: Net Income Climbs 31%, Combined Ratio Hits 95.9%, and a Merger with American Family Is Announced
BOW sits 59% above its 52-week low of $21.21 on elevated volume (6.3× avg).
Summary
Bowhead Specialty posted Q2 2026 net income of $16.1 million, up 31% year-over-year, with a combined ratio of 95.9%. The company also disclosed a definitive agreement to be acquired by American Family Insurance for $34 per share in cash.
Key Events · Earnings and Guidance · BOW
-
Q2 Net Income Rises 31%
Net income reached $16.1 million, or $0.48 per diluted share, compared to $12.3 million, or $0.36 per share, in Q2 2025.
-
Combined Ratio Improves to 95.9%
The combined ratio improved 0.9 points year-over-year, driven by a 2.0-point decrease in the expense ratio, partially offset by a 1.1-point increase in the loss ratio.
-
Gross Written Premiums Grow 28%
Gross written premiums increased to $297.9 million, led by the Casualty division and the scaling Baleen Specialty platform.
-
Merger Agreement with American Family
On August 2, 2026, Bowhead entered into a definitive merger agreement to be acquired by American Family Insurance for $34 per share in cash, a $1.2 billion transaction.
Analysis · BOW · Finance
Strong Q2 results underscore Bowhead Specialty's profitable growth, with net income jumping 31% to $16.1 million and the combined ratio improving to 95.9%, fueled by a 28% surge in premiums and higher investment income. The quarter's performance reinforces the company's trajectory. However, the filing also discloses a subsequent event: a definitive merger agreement with American Family Insurance at $34 per share in cash, valuing the company at $1.2 billion. Announced concurrently with the 10-Q, this acquisition is the dominant market-moving event, effectively capping the standalone equity story and shifting focus to deal completion and regulatory approvals.
At the time of this filing, BOW was trading at $33.70 on NYSE in the Finance sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $21.21 to $35.07. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.